New hope for ovarian cancer treatment
The Therapeutic Goods Administration (TGA) has approved a drug called Zejula in the treatment for women suffering from advanced high-grade ovarian cancer and chemotherapy resistance. CEO of Ovarian Cancer Australian Jane Hill said that the introduction of Zejula will be a welcome step forward in helping women to combat ovarian, fallopian and primary peritoneal cancer.…